# Vincerx Pharma, Inc.

Vincerx Pharma, Inc. is a company headquartered in Palo Alto, CA, United States.

## Company overview

- **Legal name:** Vincerx Pharma, Inc.
- **Former names in filing history:** Vincera Pharma, Inc. (2020-11-06 to 2021-01-05); LifeSci Acquisition Corp. (2019-12-12 to 2020-12-22)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Palo Alto, CA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001796129

## About

Vincerx Pharma, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001796129, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-27, it reported net income of USD -30,074,000; total assets of USD 8,005,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Net income:** -$30.1M (USD -30,074,000)
- **Total assets:** $8.0M (USD 8,005,000)
- **Cash and equivalents:** $5.0M (USD 4,987,000)
- **Operating cash flow:** -$26.1M (USD -26,127,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$40.2M (USD -40,157,000)
- **Total assets:** $18.2M (USD 18,217,000)
- **Cash and equivalents:** $12.8M (USD 12,782,000)
- **Operating cash flow:** -$40.5M (USD -40,453,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$65.4M (USD -65,367,000)
- **Total assets:** $59.3M (USD 59,286,000)
- **Cash and equivalents:** $11.7M (USD 11,663,000)
- **Operating cash flow:** -$59.6M (USD -59,604,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2021 (period ended 2021-12-31)

- **Net income:** -$39.3M (USD -39,306,000)
- **Total assets:** $117.7M (USD 117,676,000)
- **Cash and equivalents:** $111.6M (USD 111,564,000)
- **Operating cash flow:** -$33.4M (USD -33,402,000)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2025-07-07 — period 2025-06-30 — 8-K
- Form 10-Q — filed 2025-05-15 — period 2025-03-31 — 10-Q
- Form DEF 14A — filed 2025-05-12 — period 2025-06-18 — DEF 14A
- Form 8-K — filed 2025-04-17 — period 2025-04-14 — 8-K
- Form 8-K — filed 2025-04-11 — period 2025-04-07 — 8-K
- Form 10-K — filed 2025-03-27 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-03-18 — period 2025-03-14 — 8-K
- Form 8-K — filed 2025-02-28 — period 2025-02-25 — 8-K
- Form 8-K — filed 2025-02-18 — period 2025-02-11 — 8-K
- Form 8-K — filed 2025-02-06 — period 2025-01-31 — 8-K
- Form 8-K — filed 2025-01-23 — period 2025-01-23 — 8-K
- Form 8-K — filed 2025-01-23 — period 2025-01-23 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/vincerx-pharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology